Abbott Wants Developmental Delays Kept From Depakote Trial
By Brandon Lowrey ( September 29, 2015, 10:13 PM EDT) -- Abbott Laboratories and AbbVie Inc. told an Ohio federal judge Monday that the mother of a girl with birth defects allegedly caused by the companies' anti-epilepsy drug Depakote shouldn't be able to recover damages based on her daughter's developmental delays because an underlying failure to warn claim was preempted....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.